Indefinite Delivery Contract 36C24223D0044
Award Date
2/13/23
Last Date to Order
2/12/26
Federal Agency
Veterans Integrated Service Network 2
Awardee
Cytopath Biopsy Lab Inc.
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) to Cytopath Biopsy Lab Inc., doing business as Cblpath. The contract, valued at $322,400, is for the provision of cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs for veterans. Cblpath, a for-profit organization specializing in cancer diagnostics, has previously provided similar...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular diagnostic testing services to support cancer screening and diagnosis programs for veterans. Under this $838,000 single-award IDC, Cblpath will deliver firm fixed price task orders to perform ThyroSeq genetic testing at their facilities in Port Chester, New York and Gobernador Piñero,...
This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) to Cytopath Biopsy Lab Inc., operating as Cblpath, to provide ThyroSeq laboratory tests to determine the malignancy of thyroid nodules in order to support surgical decisions for veterans. The single-award IDC has a ceiling value of $500,000 and a period of performance through August 6, 2026. Under this IDC, the VA has issued multiple firm-fixed-price delivery orders ranging from $22,000 to $72,000...
The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq genomic classifier tests. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, and has held multiple federal contracts with the VA and Defense Health Agency to deliver ThyroSeq testing to support cancer screening and diagnosis programs for...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 (VA-VHA) awarded a single-award Blanket Purchase Agreement (BPA) Call contract to Cytopath Biopsy Lab Inc., doing business as Cblpath, for ThyroSeq testing services. With a period of performance from September 1, 2023 through August 31, 2024 and potential value of $360,000, the firm fixed price BPA Call aims to procure molecular diagnostic testing of thyroid nodules utilizing Cblpath's...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded Cytopath Biopsy Lab Inc., doing business as Cblpath, an indefinite-delivery, indefinite-quantity blanket purchase agreement to provide thyroid testing services. Under the BPA, the awardee received three firm fixed price call contracts totaling $1.44M to conduct thyroid testing laboratory services, thyroid sequencing testing, and thyroid testing lab services in Boston, Massachusetts;...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Cytopath Biology Lab Inc. to provide cytopathology and ThyroSeq testing services. Under the contract, Cytopath Biology Lab Inc. leverages its Cblpath division to conduct diagnostic pathology testing at its laboratory in Lebanon, Pennsylvania. Three firm fixed price delivery orders have been issued against the contract to date, valued at...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide molecular thyroid mutation reference testing services. The solicitation aimed to procure specialized diagnostic testing to help determine if thyroid nodules detected in veterans were benign or malignant. Under the IDV, Cblpath has received four firm fixed price call orders totaling $372,000...
The federal contract IDV award, valued at up to $890,640.00, was issued by the Department of Veterans Affairs' (VA) Veterans Integrated Service Network 16 (VISN 16) to Veracyte, Inc., a for-profit provider of genomic testing services. The single-award IDV, awarded on October 1, 2024 with a potential completion date of September 30, 2029, will enable VISN 16 to efficiently access Veracyte's commercial laboratory capabilities for specialized pathology testing to support VA hospitals and clinics...
The U.S. Department of Veterans Affairs (VA), through its Veterans Health Administration's Veterans Integrated Service Network 23 (VHA VISN 23), awarded a single-award indefinite-delivery contract (IDC) to Physicians Laboratory, P.C., doing business as Physicians Laboratory Services, Inc., a for-profit organization. The $6,794,619.50 IDC, awarded in April 2022, has a performance period through March 31, 2027 and provides for the delivery of offsite pathology laboratory testing services to...